Dr. Richards is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Luther Ln
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-410-0051
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1986 - 1988
- University of ChicagoResidency, Internal Medicine, 1983 - 1986
- Weill Cornell MedicineClass of 1983
Certifications & Licensure
- IL State Medical License 1983 - 2026
- MD State Medical License 1986 - 1987
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 882 citationsAdjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialAlexander M.M. Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D. Wolchok
The Lancet. Oncology. 2015-05-01 - 12 citationsIntratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.Brendan D Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries
Journal for Immunotherapy of Cancer. 2022-12-01 - 35 citationsPhase I Evaluation of Humanized OKT3 Toxicity and Immunomodulatory Effects of hOKT3γ4Jon M. Richards, Julie A. Auger, Donna Peace, Danielle Gale, Judy Michel
Cancer Research. 1999-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: